Previous close | 1.1600 |
Open | 1.0900 |
Bid | 1.1100 |
Ask | 1.2200 |
Strike | 36.00 |
Expiry date | 2024-08-02 |
Day's range | 1.0900 - 1.0900 |
Contract range | N/A |
Volume | |
Open interest | 36 |
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Smith-Midland Corporation (SMID) and Crimson Wine Group, Ltd. (CWGL).
BP has agreed to buy Bunge's 50% interest in their joint venture (JV), BP Bunge Bioenergia. The $1.4 billion deal will give BP full ownership of the JV, enabling streamlined operations and a refined focus on profitable biofuel developments.
BP (BP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.